Clinical Trials and Representation

Published on: 

This segment conveys the importance of decentralizing clinical trials to increase diversity and serve all types of people in the United States, as well as the industry. In addition, it touches on the importance of having diverse investigators to help recruit and communicate with all types of people.

Related Content:

Pharm Exec VideoDE&I
Health Equity in Pharma: Q&A with ZS
Bridging the Health Equity Gap in Clinical Development
Building Up Health Equity: Q&A With Ian Thompson and Ponda Motsepe-Ditshego of Amgen